BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 18, 2024
See today's BioWorld
Home
» Other news to note for Oct. 6, 2020
X
Upgrade your daily dose of biopharma and medtech news
Subscribe to BioWorld™ news services
See subscription options
To read the full article
sign up for free
or
sign in
.
Other news to note for Oct. 6, 2020
Oct. 6, 2020
No Comments
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: 4basebio, Acacia, Aim Immunotech, Akari, Argenx, Aro, Applied Biomath, ATCC, Atomwise, Beigene, Bioatla, Bostongene, Chugai, Dermavant, Derm-Biome, Eisai, GT, Hemogenyx, Hepalink, ILC, Imbio, Ionis, Kaleido, Molecular Partners, Moleculin, Mustang, NEC, Ocugen, Oncimmune, Oxford Biomedica, Respirerx, Roche, Sirion, Taysha Gene, Transgene, Xilio.
BioWorld
Briefs
Other news to note
Coronavirus